Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide.

British Journal of Pharmacology
H XuAndrew J McLachlan

Abstract

Patients commonly take complementary medicines in conjunction with conventional drugs without clear evidence of safety or the risk of herb-drug interactions. The aim of this study was to assess potential pharmacokinetic (PK) and pharmacodynamic (PD) interactions between St John's wort and gliclazide in healthy subjects with different cytochrome P450 2C9 (CYP2C9) genotypes. A crossover controlled study was conducted in 21 healthy subjects. Each received gliclazide (80 mg) either alone or during 15 days treatment with St John's wort. The area under the plasma concentration-time curve (AUC(0-infinity)), apparent clearance (CL/F) and elimination half-life (t 1/2) of gliclazide and incremental changes in glucose and insulin AUC(0-4) were compared. CYP2C9*2 and CYP2C9*3 alleles were identified using PCR followed by restriction enzyme digestion analysis. St John's wort significantly altered gliclazide pharmacokinetics in all except for four healthy subjects. The mean ratio and 90% confidence interval (CI) of gliclazide AUC(0-infinity) and CL/F were 0.67 (0.55-0.81) and 1.50 (1.24-1.81), respectively, after St John's wort treatment. St John's wort decreased gliclazide t (1/2), with mean ratio and 90% CI of 0.85 (0.74-0.93). There were ...Continue Reading

References

Jan 1, 1991·Diabetes Research and Clinical Practice·D B CampbellC Nathan
Aug 11, 1987·European Journal of Pharmacology·B Lupo, D Bataille
Jan 1, 1985·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·T OidaT Higashijima
Apr 6, 1996·Lancet·E Ernst
Aug 1, 1996·Pharmacogenetics·T H Sullivan-KloseJ A Goldstein
Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·S S HongC K Shim
Feb 22, 2000·Lancet·S C PiscitelliJ Falloon
Mar 16, 2000·British Journal of Clinical Pharmacology·T M DavisP H Barrett
Jun 15, 2000·Proceedings of the National Academy of Sciences of the United States of America·L B MooreS A Kliewer
Apr 25, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·E A RyanC Marceau
Aug 7, 2001·Journal of the American Pharmaceutical Association : APhA·M WurglicsM Schubert-Zsilavecz
Dec 26, 2001·Clinical Pharmacology and Therapeutics·K SugimotoA Fujimura
Jan 25, 2003·Clinical Pharmacology and Therapeutics·George K DresserRichard B Kim
Oct 10, 2003·Clinical Pharmacology and Therapeutics·Ji-Young ParkJae-Gook Shin
Nov 6, 2003·The Journal of Pharmacology and Experimental Therapeutics·Yuping ChenJoyce A Goldstein
Apr 6, 2004·Clinical Chemistry and Laboratory Medicine : CCLM·Elizabeta TopićMarina Samardzija
Apr 20, 2004·British Journal of Clinical Pharmacology·Xuemin JiangAndrew J McLachlan
Jul 3, 2004·BMJ : British Medical Journal·Edward MillsGordon Guyatt
Oct 8, 2004·Clinical Pharmacology and Therapeutics·Ingrid MaiIvar Roots
Jan 10, 2006·The Medical Journal of Australia·Alastair H MacLennanAnne W Taylor
Apr 25, 2006·Metabolism: Clinical and Experimental·Kenneth M Shaw
Feb 15, 2007·British Journal of Clinical Pharmacology·Yifan ZhangDafang Zhong
May 23, 2007·British Journal of Clinical Pharmacology·David J ElliotJohn O Miners

❮ Previous
Next ❯

Citations

Oct 1, 2013·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·P K PrabhakarMukesh Doble
Jun 1, 2011·Therapeutic Advances in Endocrinology and Metabolism·Pranav Kumar Prabhakar, Mukesh Doble
Jun 16, 2009·Chinese Medicine·Hongxiang HuiVay Liang W Go
Dec 20, 2012·Expert Review of Molecular Diagnostics·Miao HuBrian Tomlinson
May 23, 2012·Expert Opinion on Drug Metabolism & Toxicology·Roja Rahimi, Mohammad Abdollahi
Jun 24, 2009·Expert Opinion on Drug Metabolism & Toxicology·Wenxia ZhangLee Yong Lim
Nov 17, 2012·Expert Opinion on Drug Metabolism & Toxicology·Andreas HolsteinPeter Kovacs
Jan 7, 2014·Expert Opinion on Drug Metabolism & Toxicology·Walter Emil Haefeli, Alexandra Carls
Mar 31, 2015·Evidence-based Complementary and Alternative Medicine : ECAM·Mou-Ze LiuWei Zhang
Mar 24, 2016·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Jin Gyu ChoiMyung Sook Oh
Apr 1, 2014·Orvosi hetilap·Gábor Winkler
Oct 18, 2005·The Medical Clinics of North America·Christopher P HolstegeR Brent Furbee
Mar 28, 2006·International Journal of Antimicrobial Agents·Dominique LevêqueRaoul Herbrecht
Oct 10, 2009·Integrative Cancer Therapies·Stacy S ShordAlvina Lukose
Apr 20, 2016·Therapeutic Advances in Endocrinology and Metabolism·Marcus May, Christoph Schindler
Apr 22, 2018·Biopharmaceutics & Drug Disposition·Mastan ShaikEswar Kumar Kilari
Sep 14, 2010·Phytotherapy Research : PTR·Parisa Hasanein, Siamak Shahidi
Feb 8, 2018·The Journal of Pharmacy and Pharmacology·Sigrun Chrubasik-HausmannAndrew J McLachlan
Apr 17, 2009·Clinical Pharmacology and Therapeutics·S V VormfeldeJ Kirchheiner
Jun 25, 2010·British Journal of Clinical Pharmacology·Mohi Iqbal Mohammed AbdulAndrew J McLachlan
Dec 21, 2010·Wiener medizinische Wochenschrift·Matthias Unger
Apr 9, 2009·Nature Reviews. Urology·Barrie R CassilethK Simon Yeung
Jan 20, 2012·Clinical Pharmacokinetics·Shaojun Shi, Ulrich Klotz
Jan 24, 2014·Therapeutic Drug Monitoring·Eman M Alissa
Apr 29, 2018·Journal of Food and Drug Analysis·Manuela Grimstein, Shiew-Mei Huang
Nov 29, 2017·European Journal of Clinical Pharmacology·Sijie LuA S Gross
Feb 10, 2012·JAAPA : Official Journal of the American Academy of Physician Assistants·John Laird
Jul 31, 2021·Biopharmaceutics & Drug Disposition·Jeffry Adiwidjaja, Lucy Sasongko
Aug 27, 2021·Medicines·Mary Beth BabosPaul Herscu
Mar 9, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Sushant ShenguleBhushan Patwardhan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.